
Galip Can Uyar/LinkedIn
May 10, 2025, 17:34
Galip Can Uyar: Prediction of 90-day Mortality Among Cancer Patients with Unplanned Hospitalisation
Galip Can Uyar, Medical Oncologist at Etlik City Hospital, shared a post on LinkedIn:
“Proud to present our latest work in The Lancet Regional Health – Europe!
We present the first external validation of the PROMISE Score outside Spain and introduce the novel PROMISE–CTI Combined Score (AUC: 0.884 | Sens: 92.4% | Spec: 81.1%) for predicting 90-day mortality in hospitalised cancer patients.
Prospective multicentre validation is underway!”
Title: Prediction of 90-day mortality among cancer patients with unplanned hospitalisation: a retrospective validation study of three prognostic scores
Authors: Galip Can Uyara ∙ Oriol Mirallasb ∙ Kadriye Başkurta ∙ Berta Martin-Cullellc ∙ Enes Yeşilbaşa ∙ Jordi Recuero-Boraud ∙ Seher Kayaa ∙ Victor Navarro Garcése ∙ Sevgi Eryıldız Yücela ∙ Kreina Sharela Vega Canob ∙ Diego Gómez-Puertob ∙ Anna Pedrola Gómeze ∙ Clara Salva de Torresb ∙ Ömür Berna Çakmak Öksüzoğlua ∙ Sonia Serradellb ∙ Rodrigo Dienstmanne ∙ Osman Sütcüoğlu
You can read the Full Text on The Lancet Regional Health – Europe.
More posts featuring Galip Can Uyar.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 10, 2025, 16:16